JW Women's Health -- 2006 (831): 1 Table 1

Skip to Content
Skip to Navigation
Skip to Utility Navigation
Skip to Search

Table 1. Oral Contraceptive Formulations That Reduce or Eliminate the Hormone-Free Interval

Product Formulation Dosing Regimen

Loestrin 24 Fe EE 20 ìg/NETA 1 mg 24 days active + 4 days placebo

YAZ EE 20 ìg/DRSP 3 mg 24 days active + 4 days placebo

Seasonale EE 30 ìg/LNG 150 ìg 84 days active + 7 days placebo

Seasonique EE 30 ìg/LNG 150 ìg, EE 10 ìg 84 days active + 7 days low-dose EE

DRSP = Drosperinone, EE = ethinyl estradiol, LNG = levonorgestrel, NETA = norethindrone